Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XDH | P47989 | 3/20 | 0.46 |
| ▸ | POLA1 | P09884 | 1/20 | 0.40 |
| ▸ | PI4KA | P42356 | 1/20 | 0.40 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 0.40 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 0.40 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.40 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PNP | P00491 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9059982 | 0.85 | XDH (0.43) | XDHPOLA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL7809880 | 0.84 | XDH (0.61) | XDHPOLA1PI4KAPI4K2BPI4K2A | |
| SCHEMBL7862549 | 0.76 | PBK (0.36) | XDHALDH1A1PNP | |
| SCHEMBL6272728 | 0.76 | PNP (0.58) | PI4KAPI4K2BPI4K2API4KBALDH1A1 | |
| SCHEMBL8522269 | 0.71 | PNP (0.56) | PI4KAPI4K2BPI4K2API4KBGPR84 | |
| SCHEMBL8536005 | 0.70 | PNP (0.54) | PI4KAPI4K2BPI4K2API4KBGPR84 | |
| SCHEMBL6272296 | 0.70 | PNP (0.54) | PI4KAPI4K2BPI4K2API4KBGPR84 | |
| SCHEMBL7777164 | 0.70 | PNP (0.54) | PI4KAPI4K2BPI4K2API4KBGPR84 | |
| SCHEMBL4384740 | 0.69 | XDH (0.67) | XDHPOLA1GPR84ALDH1A1PNP | |
| Hydrochloric Acid SCHEMBL258896 | 0.69 | PNP (0.53) | PI4KAPI4K2BPI4K2API4KBGPR84 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210147502-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | UNIV VIRGINIA COMMONWEALTH (US) | 2021-05-20 | — | — | US | disclosed |
| US-20200384135-A1 | CANCER IMAGING WITH THERAPY: THERANOSTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2020-12-10 | — | — | US | disclosed |
| EP-3004153-B1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | UNIV VIRGINIA COMMONWEALTH (US) | 2019-10-30 | — | — | EP | disclosed |
| US-10166300-B2 | Tripartite cancer theranostic nucleic acid constructs | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2019-01-01 | — | — | US | disclosed |
| US-20180305429-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | UNIV VIRGINIA COMMONWEALTH (US) | 2018-10-25 | — | — | US | disclosed |
| US-9951114-B2 | Recombinant cancer therapeutic cytokine | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-04-24 | — | — | US | disclosed |
| EP-3003022-B1 | USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS | UNIV VIRGINIA COMMONWEALTH (US) | 2017-11-22 | — | — | EP | disclosed |
| EP-3004872-B1 | MDA-9/SYNTENIN PROMOTER TO IMAGE AND TREAT METASTATIC CANCER CELLS | UNIV VIRGINIA COMMONWEALTH (US) | 2017-10-18 | — | — | EP | disclosed |
| US-9750823-B2 | Use of a truncated CCN1 promoter for cancer diagnostics, therapeutics and theranostics | UNIV VIRGINIA COMMONWEALTH (US) | 2017-09-05 | — | — | US | disclosed |
| US-9701985-B2 | mda-9/syntenin promoter to image and treat metastatic cancer cells | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2017-07-11 | — | — | US | disclosed |
| EP-3003022-A1 | USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS | Virginia Commonwealth University (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014209553-A1 | USE OF A TRUNCATED CCN1 PROMOTER FOR CANCER DIAGNOSTICS, THERAPEUTICS AND THERANOSTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2014-12-31 | — | — | WO | disclosed |
| WO-2014197598-A2 | TRIPARTITE CANCER THERANOSTIC NUCLEIC ACID CONSTRUCTS | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-12-11 | — | — | WO | disclosed |
| WO-2014197535-A1 | RECOMBINANT CANCER THERAPEUTIC CYTOKINE | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2014-12-11 | — | — | WO | disclosed |
| US-20140227182-A1 | CANCER IMAGING WITH THERAPY: THERANOSTICS | THE JOHNS HOPKINS UNIVERSITY (US) | 2014-08-14 | — | — | US | disclosed |
| US-20130263296-A1 | CANCER IMAGING WITH THERAPY: THERANOSTICS | THE JOHNS HOPKINS UNIVERSITY (US) | 2013-10-03 | — | — | US | disclosed |
| EP-2633063-A2 | CANCER IMAGING WITH THERAPY: THERANOSTICS | Virginia Commonwealth University (US) | 2013-09-04 | — | — | EP | disclosed |
| WO-2012058522-A2 | CANCER IMAGING WITH THERAPY: THERANOSTICS | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2012-05-03 | — | — | WO | disclosed |
| EP-1372664-A1 | USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES | Hollis-Eden Pharmaceuticals Inc. (US) | 2004-01-02 | — | — | EP | disclosed |
| WO-2002069977-A1 | USE OF CERTAIN STEROIDS FOR TREATMENT OF BLOOD CELL DEFICIENCIES | HOLLIS-EDEN PHARMACEUTICALS, INC. (US) | 2002-09-12 | — | — | WO | disclosed |